| Julia Wilkins, | |
|
213 Lancaster Gate Ln Apt 206, Midlothian, VA 23113-6898 | |
| (804) 519-1463 | |
| Not Available |
| Full Name | Julia Wilkins |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 213 Lancaster Gate Ln Apt 206, Midlothian, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033582754 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 0710102279 (Virginia) | Secondary |
| 1041C0700X | Social Worker - Clinical | 0904009178 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julia Wilkins, 213 Lancaster Gate Ln Apt 206, Midlothian, VA 23113-6898 Ph: (804) 519-1463 | Julia Wilkins, 213 Lancaster Gate Ln Apt 206, Midlothian, VA 23113-6898 Ph: (804) 519-1463 |
News Archive
In a novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long-term treatment using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative condition.
New research from the University, published in the Archives of Disease in Childhood journal, shows a strong link between childhood obesity and hip diseases in childhood.
Although surgery can prolong the lives of patients with an aggressive type of cancer called malignant pleural mesothelioma, many patients avoid the operation for fear it will degrade their quality of life.
Diagnosing Alzheimer's disease and determining a patient's prognosis is an inexact business, and that stands in the way of better personalized care and advances in treatment.
› Verified 7 days ago